1. Healthcare

  2. •

    Drug Manufacturers - Specialty & Generic
SciClone Pharmaceuticals, Inc.

SciClone Pharmaceuticals, Inc.

SCLN
SciClone Pharmaceuticals, Inc.US flagNASDAQ
11.15
USD
- -
- -
SciClone Pharmaceuticals, Inc.
SCLN
(NASDAQ)

Recent

price

11.15

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available
Similar Companies
CBD Life Sciences Inc. (CBDL)
CuraScientific Corp. (BNOWD)
Planet Based Foods Global Inc. (PBFFF)
Chill Brands Group PLC (CHBRF)
Jinhe Biotechnology Co. Ltd. (002688.SZ)
Taisho Pharmaceutical Holdings Co., Ltd. (TAISF)
Business
SciClone Pharmaceuticals, Inc. now functions as a specialty biopharmaceutical enterprise, with its core commercial and development activities centered on the dynamic healthcare market of Greater China. The company concentrates on the acquisition, advancement, and marketing of critical treatments for significant health challenges, particularly within the fields of oncology and severe infections, including key products for hepatitis management and immune system modulation.